Objective: To evaluate the clinical effectiveness of endoscopic removal of spinal infections and posterior pedicle surgery, including bone grafting, fixation, and chemotherapy, and to outline preventive strategies for complications, offering guidance for clinical practice.
Methods: 128 spinal infectious disease patients (2018-2022) were categorized into Group A (endoscopic removal, n=44) and Group B (posterior pedicle removal+bone grafting+fixation, n=84). Pre-surgery, all received quadruple antibiotic therapy. Metrics tracked: operation time, blood loss, drainage, recovery, stay, transfusion, complications, and pre/post-surgery VAS, ODI, ESR, CRP, PCT, D-dimer, NLR, Hb, albumin.
Results: (1) Preoperative data: There were no statistically significant differences in age, gender, body mass index, involved segments, past medical history (cardiovascular and cerebrovascular diseases, respiratory diseases, endocrine system diseases, metabolic diseases and tuberculosis), smoking history, preoperative erythrocyte sedimentation rate, C-reactive protein, procalcitonin, D-dimer, lymphocyte and neutrophil-lymphocyte ratio, hemoglobin, total protein, waist VAS score and waist ODI score (P>0.05). (2) The main postoperative indexes were significantly lower than those of group B at the last follow-up at 3 months and the last follow-up in group A, and the difference was significant (P<0.05), the hemoglobin and total protein in group A were significantly higher than those in group B at the last postoperative follow-up (P<0.05), and the recurrence rate in group B was significantly higher than that in group A, and the difference was significant (P=0.048). (3) Postoperative secondary indicators: the amount of blood transfusion in group A was significantly lower than that in group B, and the difference between the two groups was statistically significant (P<0.05), while the operation time, intraoperative blood loss and postoperative hospital stay in group A were significantly smaller than those in group B, and the difference between the two groups was statistically significant (P<0.05).
Conclusion: Endoscopic lesion removal for spinal infections achieves similar safety to posterior pedicle surgery, with shorter operation time, less blood loss, lower recurrence, and reduced drainage. It enhances ESR, spine function, and pain relief, meriting promotion.
目的评估脊柱感染内镜下切除和后椎弓根手术(包括植骨、固定和化疗)的临床效果,并概述并发症的预防策略,为临床实践提供指导。方法:将128例脊柱感染性疾病患者(2018-2022年)分为A组(内镜下切除,n=44)和B组(后椎弓根切除+植骨+固定,n=84)。手术前,所有患者均接受四重抗生素治疗。跟踪指标:手术时间、失血量、引流量、恢复情况、住院时间、输血量、并发症以及手术前后的 VAS、ODI、ESR、CRP、PCT、D-二聚体、NLR、Hb、白蛋白:年龄、性别、体重指数、受累节段、既往病史(心脑血管疾病、呼吸系统疾病、内分泌系统疾病、代谢性疾病和结核病)、吸烟史、术前红细胞沉降率、C 反应蛋白、降钙素原、D-二聚体、淋巴细胞和中性粒细胞-淋巴细胞比值、血红蛋白、总蛋白、腰部 VAS 评分和腰部 ODI 评分差异无统计学意义(P>0.05)。(2)术后3个月最后一次随访和A组最后一次随访的主要指标均明显低于B组,差异有学意义(PConclusion:内镜下病灶清除术治疗脊柱感染的安全性与后路椎弓根手术相似,具有手术时间短、失血少、复发率低、引流减少等优点。它能提高 ESR,改善脊柱功能,缓解疼痛,值得推广。
{"title":"Retrospective Analysis of the Efficacy and Safety of Endoscopic Spinal Tuberculosis and Brucellosis Lesion Removal and Posterior Pedicle Lesion Removal, Bone Grafting, Internal Fixation and Surgery Combined with Medical Chemotherapy in the Treatment of Spinal Tuberculosis and Brucellosis.","authors":"Aiben Kayierhan, Abuduwupuer Haibier, Aikebaierjiang Aisaiti, Alimujiang Aximu, Liang Ma, Yuntao Liu, Tuerhongjiang Abudurexiti","doi":"10.2147/IDR.S472558","DOIUrl":"10.2147/IDR.S472558","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the clinical effectiveness of endoscopic removal of spinal infections and posterior pedicle surgery, including bone grafting, fixation, and chemotherapy, and to outline preventive strategies for complications, offering guidance for clinical practice.</p><p><strong>Methods: </strong>128 spinal infectious disease patients (2018-2022) were categorized into Group A (endoscopic removal, n=44) and Group B (posterior pedicle removal+bone grafting+fixation, n=84). Pre-surgery, all received quadruple antibiotic therapy. Metrics tracked: operation time, blood loss, drainage, recovery, stay, transfusion, complications, and pre/post-surgery VAS, ODI, ESR, CRP, PCT, D-dimer, NLR, Hb, albumin.</p><p><strong>Results: </strong>(1) Preoperative data: There were no statistically significant differences in age, gender, body mass index, involved segments, past medical history (cardiovascular and cerebrovascular diseases, respiratory diseases, endocrine system diseases, metabolic diseases and tuberculosis), smoking history, preoperative erythrocyte sedimentation rate, C-reactive protein, procalcitonin, D-dimer, lymphocyte and neutrophil-lymphocyte ratio, hemoglobin, total protein, waist VAS score and waist ODI score (P>0.05). (2) The main postoperative indexes were significantly lower than those of group B at the last follow-up at 3 months and the last follow-up in group A, and the difference was significant (P<0.05), the hemoglobin and total protein in group A were significantly higher than those in group B at the last postoperative follow-up (P<0.05), and the recurrence rate in group B was significantly higher than that in group A, and the difference was significant (P=0.048). (3) Postoperative secondary indicators: the amount of blood transfusion in group A was significantly lower than that in group B, and the difference between the two groups was statistically significant (P<0.05), while the operation time, intraoperative blood loss and postoperative hospital stay in group A were significantly smaller than those in group B, and the difference between the two groups was statistically significant (P<0.05).</p><p><strong>Conclusion: </strong>Endoscopic lesion removal for spinal infections achieves similar safety to posterior pedicle surgery, with shorter operation time, less blood loss, lower recurrence, and reduced drainage. It enhances ESR, spine function, and pain relief, meriting promotion.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11346488/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142072674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Perianal infection has a high incidence and mortality rate in patients with acute myeloid leukemia (AML). Sometimes there is a lack of effective anti-infective treatment regimens.
Case presentation: A 58-year-old male diagnosed with AML presented with secondary perianal infection and septic shock upon admission. Although multiple pathogen cultivation and antibiotic sensitivity tests indicated the presence of sensitive strains, the corresponding antibiotics were ineffective. As a last resort, carrimycin was introduced, ultimately controlling the infection and leading to disease remission.
Conclusion: Carrimycin is a complementary treatment option when conventional antibiotic therapy fails. It operates through multiple mechanisms beyond its antibiotic properties and warrants further investigation.
{"title":"Carrimycin in a Patient with Acute Myeloid Leukemia Complicated with Life-Threatening Mixed Perianal Infection: A Case Report and Literature Review.","authors":"Xiawan Yang, Yingying Shen, Tonglin Hu, Hangchao Li, Yun Zhang, Yiping Shen, Dijiong Wu","doi":"10.2147/IDR.S475982","DOIUrl":"10.2147/IDR.S475982","url":null,"abstract":"<p><strong>Background: </strong>Perianal infection has a high incidence and mortality rate in patients with acute myeloid leukemia (AML). Sometimes there is a lack of effective anti-infective treatment regimens.</p><p><strong>Case presentation: </strong>A 58-year-old male diagnosed with AML presented with secondary perianal infection and septic shock upon admission. Although multiple pathogen cultivation and antibiotic sensitivity tests indicated the presence of sensitive strains, the corresponding antibiotics were ineffective. As a last resort, carrimycin was introduced, ultimately controlling the infection and leading to disease remission.</p><p><strong>Conclusion: </strong>Carrimycin is a complementary treatment option when conventional antibiotic therapy fails. It operates through multiple mechanisms beyond its antibiotic properties and warrants further investigation.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11345016/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142055443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-19eCollection Date: 2024-01-01DOI: 10.2147/IDR.S468413
Ning Du, Dan You, Dava Tenzing, Dongxiang Qu, Jun Meng, Yihui Wang, Juan He
Purpose: Infection with carbapenem-resistant Acinetobacter baumannii (CRAB) is a tough nut to crack. Carrimycin is a novel recombinant macrolide antibiotic, and has good anti-infection effects in vivo. At present, it is rarely reported for treatment of CRAB infection. We present a case where a patient with COVID-19 complicated by CRAB infection was successfully treated with a combination therapy including carrimycin, offering clinical insights and experience.
Patients and methods: The patient infected with CRAB was cured by carrimycin combined with tigecycline and amikacin ultimately. We analyzed and summarized the therapeutic regimen and disease feature to provide reference for clinical treatment.
Results: The patient was admitted to emergency observation wards with fever and was diagnosed with COVID-19 pneumonia. During the treatment, his condition worsened. He had a fever, cough, and expectoration. After 3 days of empirical treatment with meropenem, tested positive for A. baumannii infection by the next-generation sequencing, and CRAB was detected in blood and sputum culture. Then, he was administered with tigecycline and amikacin immediately for 5 days, however the therapeutic effect was not significant. The patient still remained in a high inflammatory response. Ultimately, the treatment regimen was changed to carrimycin combined with tigecycline and amikacin for 7 days, and then carrimycin combined with tigecycline for 10 days, the patient's clinical condition gradually improved. The patient received carrimycin monotherapy for 7 days, then discharged.
Conclusion: Carrimycin may be a bright alternative for CRAB infection as one of the drugs in combination therapy, especially in a patient with hyperinflammatory response.
{"title":"Carrimycin, as One of the Drugs in Combination Therapy, for the Treatment of Carbapenem-Resistant <i>Acinetobacter Baumannii</i> Infection.","authors":"Ning Du, Dan You, Dava Tenzing, Dongxiang Qu, Jun Meng, Yihui Wang, Juan He","doi":"10.2147/IDR.S468413","DOIUrl":"10.2147/IDR.S468413","url":null,"abstract":"<p><strong>Purpose: </strong>Infection with carbapenem-resistant <i>Acinetobacter baumannii</i> (CRAB) is a tough nut to crack. Carrimycin is a novel recombinant macrolide antibiotic, and has good anti-infection effects in vivo. At present, it is rarely reported for treatment of CRAB infection. We present a case where a patient with COVID-19 complicated by CRAB infection was successfully treated with a combination therapy including carrimycin, offering clinical insights and experience.</p><p><strong>Patients and methods: </strong>The patient infected with CRAB was cured by carrimycin combined with tigecycline and amikacin ultimately. We analyzed and summarized the therapeutic regimen and disease feature to provide reference for clinical treatment.</p><p><strong>Results: </strong>The patient was admitted to emergency observation wards with fever and was diagnosed with COVID-19 pneumonia. During the treatment, his condition worsened. He had a fever, cough, and expectoration. After 3 days of empirical treatment with meropenem, tested positive for <i>A. baumannii</i> infection by the next-generation sequencing, and CRAB was detected in blood and sputum culture. Then, he was administered with tigecycline and amikacin immediately for 5 days, however the therapeutic effect was not significant. The patient still remained in a high inflammatory response. Ultimately, the treatment regimen was changed to carrimycin combined with tigecycline and amikacin for 7 days, and then carrimycin combined with tigecycline for 10 days, the patient's clinical condition gradually improved. The patient received carrimycin monotherapy for 7 days, then discharged.</p><p><strong>Conclusion: </strong>Carrimycin may be a bright alternative for CRAB infection as one of the drugs in combination therapy, especially in a patient with hyperinflammatory response.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11342940/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142055444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Bacillus cereus is a common bacterium found in the environment. Some strains can cause food poisoning, and very few can cause clinically severe infections, leading to death. Here, we characterized the genome sequence of B. cereus LIN78 isolated from teeth with deep caries and compared it with those of 25 other related species.
Methods: Third-generation sequencing technology, bacteriological analyses, biochemistry, and mass spectrometry were applied to characterize the drug-resistance genes and virulence factors of B. cereus LIN78.
Results: The complete genome sequence of B. cereus Lin78 consists of 5647 genes distributed on a circular chromosome, a 393 kbp plasmid, and 928 pseudogenes (37.4% of whole-genome DNA). The LIN78 genome contains 14 sets of 16s, 23s, and 5s ribosomal RNA operons; 106 tRNA genes, one tmRNA, 12 genomic islands, six prophases, 64 repeats; 37 antibiotic-resistant genes; and 1119 putative virulence genes, including enterotoxins and cytolysins. The B. cereus LIN78 genome carries multiple copies of non-ribosomal polypeptide synthetase (NRPS) and post-translationally modified peptides (RiPPs). Phylogenetic analysis of the 26 B. cereus strains showed that B. cereus LIN78 is evolutionarily closely related to B. thuringiensis ATCC 10792 and B. cereus ATCC 14579.
Conclusion: The newly isolated B. cereus carries many virulence genes, including enterotoxins and hemolysins, similar to B. anthracis, and multiple antibiotic resistance genes. These findings suggest that the strain has a potential risk of causing disease. Our studies are vital for further exploration of the evolution of B. cereus, its pathogenic mechanisms, and the control and treatment of bacterial infections.
{"title":"Genomic Insights into the Pathogenicity and Drug-Resistance of a <i>Bacillus cereus</i> Isolated from Human Teeth.","authors":"Yibin Lin, Lehua Liu, Siyang Lu, Linqi Fan, Huaqi Hu, Xuanyin Wang, Jichao Zhu, Xinhua Qiang, Jie He, Hongchang Zhou, Shengwen Shao, Gaoming Zheng","doi":"10.2147/IDR.S477637","DOIUrl":"10.2147/IDR.S477637","url":null,"abstract":"<p><strong>Background: </strong><i>Bacillus cereus</i> is a common bacterium found in the environment. Some strains can cause food poisoning, and very few can cause clinically severe infections, leading to death. Here, we characterized the genome sequence of <i>B. cereus</i> LIN78 isolated from teeth with deep caries and compared it with those of 25 other related species.</p><p><strong>Methods: </strong>Third-generation sequencing technology, bacteriological analyses, biochemistry, and mass spectrometry were applied to characterize the drug-resistance genes and virulence factors of <i>B. cereus</i> LIN78.</p><p><strong>Results: </strong>The complete genome sequence of <i>B. cereus</i> Lin78 consists of 5647 genes distributed on a circular chromosome, a 393 kbp plasmid, and 928 pseudogenes (37.4% of whole-genome DNA). The LIN78 genome contains 14 sets of 16s, 23s, and 5s ribosomal RNA operons; 106 tRNA genes, one tmRNA, 12 genomic islands, six prophases, 64 repeats; 37 antibiotic-resistant genes; and 1119 putative virulence genes, including enterotoxins and cytolysins. The <i>B. cereus</i> LIN78 genome carries multiple copies of non-ribosomal polypeptide synthetase (NRPS) and post-translationally modified peptides (RiPPs). Phylogenetic analysis of the 26 <i>B. cereus</i> strains showed that <i>B. cereus</i> LIN78 is evolutionarily closely related to <i>B. thuringiensis</i> ATCC 10792 and <i>B. cereus</i> ATCC 14579.</p><p><strong>Conclusion: </strong>The newly isolated <i>B. cereus</i> carries many virulence genes, including enterotoxins and hemolysins, similar to <i>B. anthracis</i>, and multiple antibiotic resistance genes. These findings suggest that the strain has a potential risk of causing disease. Our studies are vital for further exploration of the evolution of <i>B. cereus</i>, its pathogenic mechanisms, and the control and treatment of bacterial infections.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11342944/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142055445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-17eCollection Date: 2024-01-01DOI: 10.2147/IDR.S473416
Yuxia Fang, Yilu Zhao, Lei Qin, Ziyue Song, Ruzhi Zhang
Background: Intramuscular (IM) injection of penicillin G Benzathine (PGB) is widely recognized as the primary treatment for patients at all stages of syphilis. However, the discomfort and induration associated with PGB injections are often a challenge for patients. While lidocaine is already known to reduce injection pain and is standard practice in some countries, the added value of combining lidocaine with the z-track technique has not been thoroughly investigated. This study aims to observe the use of combining lidocaine with the Z-track technique in the treatment of syphilis, and to explore less painful methods of administering IM PGB for the treatment of syphilis in adult patients.
Methods: 32 syphilis patients requiring penicillin treatment were injected with 1.2 million units of penicillin on both sides of the buttocks. The left side was injected using the traditional method with 0.9% saline as the solvent (control Group), while the right side was injected using a "z" injection method with 0.2% lidocaine as the solvent (experimental Group). The success rate of the single injection, the intensity and duration of the post-injection pain and the induration reaction were observed and recorded.
Results: There was no statistically significant difference in single injection success rate and immediate post injection pain score between the two sides (P>0.05). However, the right side had a lower pain score at 30 minutes post injection and fewer induration reactions, showing a statistically significant difference between the two sides (P<0.05). Chi-squared analysis showed that age, gender and BMI had no significant effect on pain scores 30 minutes after injection in either the control or intervention groups. (P>0.05).
Conclusion: The lidocaine + Z-track penicillin method can reduce delayed pain and induration reactions in patients with syphilis, and provides an additional approach to improving patient comfort beyond the standard use of lidocaine alone. This method merits clinical promotion.
{"title":"Evaluation of Combined Strategy to Reduce the Pain of Penicillin G Benzathine Injection in Primary Syphilis.","authors":"Yuxia Fang, Yilu Zhao, Lei Qin, Ziyue Song, Ruzhi Zhang","doi":"10.2147/IDR.S473416","DOIUrl":"10.2147/IDR.S473416","url":null,"abstract":"<p><strong>Background: </strong>Intramuscular (IM) injection of penicillin G Benzathine (PGB) is widely recognized as the primary treatment for patients at all stages of syphilis. However, the discomfort and induration associated with PGB injections are often a challenge for patients. While lidocaine is already known to reduce injection pain and is standard practice in some countries, the added value of combining lidocaine with the z-track technique has not been thoroughly investigated. This study aims to observe the use of combining lidocaine with the Z-track technique in the treatment of syphilis, and to explore less painful methods of administering IM PGB for the treatment of syphilis in adult patients.</p><p><strong>Methods: </strong>32 syphilis patients requiring penicillin treatment were injected with 1.2 million units of penicillin on both sides of the buttocks. The left side was injected using the traditional method with 0.9% saline as the solvent (control Group), while the right side was injected using a \"z\" injection method with 0.2% lidocaine as the solvent (experimental Group). The success rate of the single injection, the intensity and duration of the post-injection pain and the induration reaction were observed and recorded.</p><p><strong>Results: </strong>There was no statistically significant difference in single injection success rate and immediate post injection pain score between the two sides (<i>P</i>>0.05). However, the right side had a lower pain score at 30 minutes post injection and fewer induration reactions, showing a statistically significant difference between the two sides (<i>P</i><0.05). Chi-squared analysis showed that age, gender and BMI had no significant effect on pain scores 30 minutes after injection in either the control or intervention groups. (<i>P>0.05</i>).</p><p><strong>Conclusion: </strong>The lidocaine + Z-track penicillin method can reduce delayed pain and induration reactions in patients with syphilis, and provides an additional approach to improving patient comfort beyond the standard use of lidocaine alone. This method merits clinical promotion.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11338166/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142017386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: Application of metagenomic next-generation sequencing (mNGS) in identifying nosocomial central nervous system (CNS) infections in critical care units remains understudied.
Methods: We conducted a retrospective analysis of microbiological results through both mNGS and routine examination of cerebrospinal fluid (CSF) samples from patients with nosocomial CNS infections. The aim of this study was to assess the clinical diagnostic effect of nosocomial mNGS in this population.
Results: The study included 26 cases of nosocomial CNS infections in total. A total of 69.2% (18/26) of the samples tested positive for mNGS, which is substantially greater than the 7.7% (2/26; p<0.05) detected through conventional techniques. Administration of antibiotics before culture is most likely the cause of the low CSF culture rate. Twenty-five pathogenic strains that were missed by standard testing. Three pathogens that were consistent with the mNGS results were positive by routine tests. Eight cases were negative by mNGS due to low pathogen CSF titres. Compared to traditional testing, mNGS demonstrated 100% sensitivity and 33.3% specificity in diagnosing CNS infections. The thirty-day mortality rate was 26.9% (7/26).
Conclusion: Routine microbiologic testing frequently falls short of detecting all neuroinvasive pathogens. Our research suggests that mNGS offers an alternative means of detecting nosocomial CNS infections. By applying mNGS to CSF samples from patients with meningitis or encephalitis, we were able to improve the ability to diagnose nosocomial neurologic infections.
{"title":"Use of Metagenomic Next-Generation Sequencing to Identify Pathogens Involved in Central Nervous System Infections.","authors":"Liying Zhan, Zhihua Lv, Yunjing Zhang, Jingdi Chen, Lu Wang, Raojuan Huang, Yaqi Sun, Wei Wu","doi":"10.2147/IDR.S474410","DOIUrl":"10.2147/IDR.S474410","url":null,"abstract":"<p><strong>Purpose: </strong>Application of metagenomic next-generation sequencing (mNGS) in identifying nosocomial central nervous system (CNS) infections in critical care units remains understudied.</p><p><strong>Methods: </strong>We conducted a retrospective analysis of microbiological results through both mNGS and routine examination of cerebrospinal fluid (CSF) samples from patients with nosocomial CNS infections. The aim of this study was to assess the clinical diagnostic effect of nosocomial mNGS in this population.</p><p><strong>Results: </strong>The study included 26 cases of nosocomial CNS infections in total. A total of 69.2% (18/26) of the samples tested positive for mNGS, which is substantially greater than the 7.7% (2/26; <i>p</i><0.05) detected through conventional techniques. Administration of antibiotics before culture is most likely the cause of the low CSF culture rate. Twenty-five pathogenic strains that were missed by standard testing. Three pathogens that were consistent with the mNGS results were positive by routine tests. Eight cases were negative by mNGS due to low pathogen CSF titres. Compared to traditional testing, mNGS demonstrated 100% sensitivity and 33.3% specificity in diagnosing CNS infections. The thirty-day mortality rate was 26.9% (7/26).</p><p><strong>Conclusion: </strong>Routine microbiologic testing frequently falls short of detecting all neuroinvasive pathogens. Our research suggests that mNGS offers an alternative means of detecting nosocomial CNS infections. By applying mNGS to CSF samples from patients with meningitis or encephalitis, we were able to improve the ability to diagnose nosocomial neurologic infections.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11339344/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142035760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-17eCollection Date: 2024-01-01DOI: 10.2147/IDR.S477180
Jun Zheng, Xiaohong Pan, Yiyun Jiang
Thrombotic thrombocytopenic purpura is a rare but life-threatening emergency. Tuberculosis can have hematologic complications. However, concurrent tuberculosis and thrombotic thrombocytopenic purpura are extremely rare. In this study, we report a 53-year-old man who was initially treated for pulmonary tuberculosis but later developed weakness and an altered mental status. Laboratory tests revealed evidence of thrombocytopenia, acute renal insufficiency, and microangiopathic hemolytic anemia. Brain imaging identified intracranial hemorrhage. Further testing revealed low ADAMTS13 activity (1.8%) and positive anti-ADAMTS13 antibody, confirming the diagnosis of thrombotic thrombocytopenic purpura. The patient had a full recovery after anti-tuberculosis treatment, plasma exchange, and supportive care. We present this rare case and review previous relevant studies to remind clinicians about the potential connections between tuberculosis and thrombotic thrombocytopenic purpura. In patients with signs of severe thrombocytopenia and microangiopathic hemolysis, necessary diagnostic tests should be performed to eliminate the possibility of thrombotic thrombocytopenic purpura occurring concurrently with tuberculosis.
{"title":"Pulmonary Tuberculosis Complicated by Thrombotic Thrombocytopenic Purpura: A Case Report and Literature Review.","authors":"Jun Zheng, Xiaohong Pan, Yiyun Jiang","doi":"10.2147/IDR.S477180","DOIUrl":"10.2147/IDR.S477180","url":null,"abstract":"<p><p>Thrombotic thrombocytopenic purpura is a rare but life-threatening emergency. Tuberculosis can have hematologic complications. However, concurrent tuberculosis and thrombotic thrombocytopenic purpura are extremely rare. In this study, we report a 53-year-old man who was initially treated for pulmonary tuberculosis but later developed weakness and an altered mental status. Laboratory tests revealed evidence of thrombocytopenia, acute renal insufficiency, and microangiopathic hemolytic anemia. Brain imaging identified intracranial hemorrhage. Further testing revealed low ADAMTS13 activity (1.8%) and positive anti-ADAMTS13 antibody, confirming the diagnosis of thrombotic thrombocytopenic purpura. The patient had a full recovery after anti-tuberculosis treatment, plasma exchange, and supportive care. We present this rare case and review previous relevant studies to remind clinicians about the potential connections between tuberculosis and thrombotic thrombocytopenic purpura. In patients with signs of severe thrombocytopenia and microangiopathic hemolysis, necessary diagnostic tests should be performed to eliminate the possibility of thrombotic thrombocytopenic purpura occurring concurrently with tuberculosis.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11338169/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142017387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: Infections cause high rates of illness and death in children worldwide. However, studies on the clinical value of metagenomic next-generation sequencing (mNGS) for immunocompromised children are still limited.
Patients and methods: From June 2021 to December 2023, 119 samples were collected at Pediatric Intensive Care Unit (PICU) of a single-center pediatric hospital and classified into two groups based on their immune states. We compared the diagnostic performance of mNGS and conventional microbiological test (CMT) for pathogen identification, and assessed the clinical impacts of mNGS.
Results: Among the 119 samples, 48 (40.34%) belonged to the immunocompromised children. mNGS had a higher positivity rate than CMT (76.47% vs 55.46%, P = 0.0006). The positive percent agreement (PPA) of mNGS for immunocompromised children was higher compared to immunocompetent children (95.24% vs 77.78%). The most common pathogens for immunocompromised patients were gram-negative bacteria and herpesvirus. However, immunocompetent children showed a higher detection rate for gram-positive bacteria and respiratory viruses. Furthermore, the proportions of the positive impact of mNGS results were significantly higher in immunocompromised patients compared to immunocompetent patients for both diagnosis (91.67% vs 57.75%) and treatment (95.83% vs 64.79%) (P < 0.0001). Immunocompromised state, length of hospital stays, times stay in ICU, Pediatric Risk of Mortality (PRISM) score, neutrophil percentage (NEUT%) and the ratio of arterial oxygen partial pressure to fractional inspired oxygen (PaO2/FiO2) were considered independent factors for poor prognosis in critically ill pediatric patients.
Conclusion: In patients from PICU, mNGS had a greater clinical significance in immunocompromised children compared to immunocompetent children. mNGS technology is an important auxiliary method for achieving accurate diagnosis and treatment of critically ill pediatric patients.
目的:感染导致全球儿童患病率和死亡率居高不下。然而,针对免疫力低下儿童的元基因组新一代测序(mNGS)的临床价值研究仍然有限:从 2021 年 6 月到 2023 年 12 月,我们在一家单中心儿科医院的儿科重症监护室(PICU)收集了 119 份样本,并根据其免疫状态分为两组。我们比较了 mNGS 和传统微生物检验(CMT)对病原体鉴定的诊断性能,并评估了 mNGS 的临床影响:在 119 份样本中,48 份(40.34%)属于免疫力低下的儿童。mNGS 的阳性率高于 CMT(76.47% vs 55.46%,P = 0.0006)。与免疫功能健全的儿童相比,免疫功能低下儿童的 mNGS 阳性率(PPA)更高(95.24% vs 77.78%)。免疫力低下患者最常见的病原体是革兰氏阴性细菌和疱疹病毒。然而,免疫功能正常的儿童对革兰氏阳性细菌和呼吸道病毒的检出率更高。此外,在诊断(91.67% vs 57.75%)和治疗(95.83% vs 64.79%)方面,免疫力低下患者的 mNGS 结果产生积极影响的比例明显高于免疫力健全患者(P < 0.0001)。免疫受损状态、住院时间、在重症监护室的住院时间、儿科死亡率风险(PRISM)评分、中性粒细胞百分比(NEUT%)和动脉血氧分压与分量吸入氧(PaO2/FiO2)之比被认为是儿科重症患者预后不良的独立因素:mNGS 技术是实现儿科重症患者准确诊断和治疗的重要辅助方法。
{"title":"Utility of Metagenomic Next-Generation Sequencing for Diagnosis of Infectious Diseases in Critically Ill Immunocompromised Pediatric Patients.","authors":"Xiangzhi Xu, Yafeng Zheng, Xiaojing Zhang, Chenmei Zhang, Wei Gai, Zihao Yang","doi":"10.2147/IDR.S472129","DOIUrl":"10.2147/IDR.S472129","url":null,"abstract":"<p><strong>Purpose: </strong>Infections cause high rates of illness and death in children worldwide. However, studies on the clinical value of metagenomic next-generation sequencing (mNGS) for immunocompromised children are still limited.</p><p><strong>Patients and methods: </strong>From June 2021 to December 2023, 119 samples were collected at Pediatric Intensive Care Unit (PICU) of a single-center pediatric hospital and classified into two groups based on their immune states. We compared the diagnostic performance of mNGS and conventional microbiological test (CMT) for pathogen identification, and assessed the clinical impacts of mNGS.</p><p><strong>Results: </strong>Among the 119 samples, 48 (40.34%) belonged to the immunocompromised children. mNGS had a higher positivity rate than CMT (76.47% vs 55.46%, <i>P</i> = 0.0006). The positive percent agreement (PPA) of mNGS for immunocompromised children was higher compared to immunocompetent children (95.24% vs 77.78%). The most common pathogens for immunocompromised patients were gram-negative bacteria and herpesvirus. However, immunocompetent children showed a higher detection rate for gram-positive bacteria and respiratory viruses. Furthermore, the proportions of the positive impact of mNGS results were significantly higher in immunocompromised patients compared to immunocompetent patients for both diagnosis (91.67% vs 57.75%) and treatment (95.83% vs 64.79%) (<i>P</i> < 0.0001). Immunocompromised state, length of hospital stays, times stay in ICU, Pediatric Risk of Mortality (PRISM) score, neutrophil percentage (NEUT%) and the ratio of arterial oxygen partial pressure to fractional inspired oxygen (PaO2/FiO2) were considered independent factors for poor prognosis in critically ill pediatric patients.</p><p><strong>Conclusion: </strong>In patients from PICU, mNGS had a greater clinical significance in immunocompromised children compared to immunocompetent children. mNGS technology is an important auxiliary method for achieving accurate diagnosis and treatment of critically ill pediatric patients.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11334925/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142008692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-16eCollection Date: 2024-01-01DOI: 10.2147/IDR.S468895
Mingyue Sun, Weiqiang Xiao, Qingxia Xu
Objective: Klebsiella michiganensis is an emerging pathogen. In this context, we characterised a strain fxq isolated from a cerebrospinal fluid specimen of a patient with tentorial meningioma, and the K. michiganensis isolate produced carbapenemases of KPC and NDM types.
Methods: The Phoenix 100 Automated Microbiology System, MALDI-TOF and whole-genome sequencing were used to identify the species. Anti-microbial susceptibility testing was also conducted with the Phoenix 100. The plasmid locations of the blaKPC-2 and blaNDM-1 genes were determined by S1-nuclease pulsed-field gel electrophoresis and Southern blot. The transfer capacity of plasmids carrying blaKPC-2 and blaNDM-1 was investigated by conjugation experiments, and the resistance plasmid stability was evaluated by culture and subculture. K. michiganensis subtypes were identified by multi-locus sequence typing. We performed whole-genome sequencing to confirm species, characterise plasmids and analyse core genes.
Results: fxq was originally identified as Klebsiella oxytoca and showed resistance to imipenem and meropenem, but whole-genome sequencing identified it to be K. michiganensis. The strain fxq belonged to the novel sequence type 202 (ST202) and carried the blaKPC-2 and blaNDM-1 genes located on the pB_KPC InFIA and pE_NDM IncU plasmids, respectively. The blaKPC-2-carrying plasmid was successfully transferred to Escherichia coli EC600 by conjugation, whereas the blaNDM-1 gene on the pE_NDM plasmid was not. The pB_KPC and pE_NDM plasmids demonstrated high stability.
Conclusion: This work is the first report on a carbapenem-resistant clinical isolate K. michiganensis ST202 harbouring the blaKPC-2 and blaNDM-1 genes encoded by the IncFIA and IncU plasmids, respectively.
目的:密歇根克雷伯氏菌是一种新出现的病原体。在此背景下,我们对从一名触珠状脑膜瘤患者的脑脊液标本中分离出的一株 fxq 菌株进行了鉴定,结果表明该米奇根氏克雷伯菌可产生 KPC 和 NDM 型碳青霉烯酶:方法:使用 Phoenix 100 自动化微生物学系统、MALDI-TOF 和全基因组测序鉴定菌种。还使用 Phoenix 100 进行了抗微生物药敏试验。通过 S1 核酸酶脉冲场凝胶电泳和 Southern 印迹确定了 bla KPC-2 和 bla NDM-1 基因的质粒位置。通过连接实验研究了携带 bla KPC-2 和 bla NDM-1 的质粒的转移能力,并通过培养和亚培养评估了抗性质粒的稳定性。通过多焦点序列分型鉴定了 K. michiganensis 亚型。我们进行了全基因组测序,以确认菌种、鉴定质粒并分析核心基因。结果:fxq最初被鉴定为克雷伯氏菌(Klebsiella oxytoca),并显示出对亚胺培南和美罗培南的耐药性,但全基因组测序确定其为K. michiganensis。fxq 菌株属于新型序列类型 202(ST202),携带 bla KPC-2 和 bla NDM-1 基因,分别位于 pB_KPC InFIA 和 pE_NDM IncU 质粒上。携带 bla KPC-2 基因的质粒通过连接成功转移到了大肠杆菌 EC600 中,而 pE_NDM 质粒上的 bla NDM-1 基因则没有成功转移。pB_KPC 和 pE_NDM 质粒表现出很高的稳定性:本研究首次报道了耐碳青霉烯类药物的临床分离株 K. michiganensis ST202 携带分别由 IncFIA 和 IncU 质粒编码的 bla KPC-2 和 bla NDM-1 基因。
{"title":"Molecular Characterization of a KPC-2- and NDM-1-Producing <i>Klebsiella michiganensis</i> Clinical Isolate in Cerebrospinal Fluid.","authors":"Mingyue Sun, Weiqiang Xiao, Qingxia Xu","doi":"10.2147/IDR.S468895","DOIUrl":"10.2147/IDR.S468895","url":null,"abstract":"<p><strong>Objective: </strong><i>Klebsiella michiganensis</i> is an emerging pathogen. In this context, we characterised a strain fxq isolated from a cerebrospinal fluid specimen of a patient with tentorial meningioma, and the <i>K. michiganensis</i> isolate produced carbapenemases of KPC and NDM types.</p><p><strong>Methods: </strong>The Phoenix 100 Automated Microbiology System, MALDI-TOF and whole-genome sequencing were used to identify the species. Anti-microbial susceptibility testing was also conducted with the Phoenix 100. The plasmid locations of the <i>bla</i> <sub>KPC-2</sub> and <i>bla</i> <sub>NDM-1</sub> genes were determined by S1-nuclease pulsed-field gel electrophoresis and Southern blot. The transfer capacity of plasmids carrying <i>bla</i> <sub>KPC-2</sub> and <i>bla</i> <sub>NDM-1</sub> was investigated by conjugation experiments, and the resistance plasmid stability was evaluated by culture and subculture. <i>K. michiganensis</i> subtypes were identified by multi-locus sequence typing. We performed whole-genome sequencing to confirm species, characterise plasmids and analyse core genes.</p><p><strong>Results: </strong>fxq was originally identified as <i>Klebsiella oxytoca</i> and showed resistance to imipenem and meropenem, but whole-genome sequencing identified it to be <i>K. michiganensis</i>. The strain fxq belonged to the novel sequence type 202 (ST202) and carried the <i>bla</i> <sub>KPC-2</sub> and <i>bla</i> <sub>NDM-1</sub> genes located on the pB_KPC InFIA and pE_NDM IncU plasmids, respectively. The <i>bla</i> <sub>KPC-2</sub>-carrying plasmid was successfully transferred to <i>Escherichia coli</i> EC600 by conjugation, whereas the <i>bla</i> <sub>NDM-1</sub> gene on the pE_NDM plasmid was not. The pB_KPC and pE_NDM plasmids demonstrated high stability.</p><p><strong>Conclusion: </strong>This work is the first report on a carbapenem-resistant clinical isolate <i>K. michiganensis</i> ST202 harbouring the <i>bla</i> <sub>KPC-2</sub> and <i>bla</i> <sub>NDM-1</sub> genes encoded by the IncFIA and IncU plasmids, respectively.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11334930/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142008691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-14eCollection Date: 2024-01-01DOI: 10.2147/IDR.S474589
Bo Liu, Yao Zhang, Zheng Yuan, Qiang Zhang
Background: Brucellosis is a zoonotic disease that can affect various organs, including the spine. Cervical spondylitis caused by Brucella is rare but can lead to significant morbidity if not diagnosed and treated promptly.
Case presentation: We report a case of a 46-year-old female who presented with intermittent high fever and intractable neck, shoulder, and back pain for two months. She was diagnosed with Brucella cervical spondylitis based on clinical manifestations, Rose-Bengal Plate Agglutination Test (RBPT, positive), and cervical MRI findings. She was treated with a combination of antibiotics for at least two weeks, followed by surgical intervention including abscess clearance, partial vertebral resection, and titanium mesh bone fusion. Real-time Polymerase Chain Reaction (RT-PCR) confirmed the presence of sheep Brucella DNA. The patient recovered well postoperatively with significant pain reduction and restoration of full mobility in the right upper limb.
Conclusion: This case highlights the diagnostic value of RT-PCR and tissue biopsy in cervical brucellosis spondylitis. Our study found that anterior cervical subtotal corpectomy can restore cervical stability, clear abscess, and relieve spinal cord compression on the basis of drug treatment, with good clinical results.
背景:布鲁氏菌病是一种人畜共患病,可影响包括脊柱在内的多个器官。由布鲁氏菌引起的颈椎炎非常罕见,但如果不及时诊断和治疗,会导致严重的发病率:我们报告了一例 46 岁女性的病例,她出现间歇性高烧和顽固性颈、肩和背部疼痛两个月。根据临床表现、玫瑰-孟加拉平板凝集试验(RBPT,阳性)和颈椎磁共振成像结果,她被诊断为布鲁氏杆菌颈椎炎。她接受了至少两周的联合抗生素治疗,随后接受了手术治疗,包括脓肿清除、部分椎体切除和钛网骨融合术。实时聚合酶链反应(RT-PCR)证实了羊布鲁氏杆菌 DNA 的存在。患者术后恢复良好,疼痛明显减轻,右上肢恢复了完全活动能力:本病例凸显了 RT-PCR 和组织活检在颈部布鲁氏菌脊柱炎中的诊断价值。我们的研究发现,前路颈椎次全椎体切除术可在药物治疗的基础上恢复颈椎稳定性、清除脓肿、解除脊髓压迫,临床效果良好。
{"title":"Cervical <i>Brucella</i> Spondylitis: A Case Report on Diagnosis and Surgical Management.","authors":"Bo Liu, Yao Zhang, Zheng Yuan, Qiang Zhang","doi":"10.2147/IDR.S474589","DOIUrl":"10.2147/IDR.S474589","url":null,"abstract":"<p><strong>Background: </strong><i>Brucellosis</i> is a zoonotic disease that can affect various organs, including the spine. Cervical spondylitis caused by <i>Brucella</i> is rare but can lead to significant morbidity if not diagnosed and treated promptly.</p><p><strong>Case presentation: </strong>We report a case of a 46-year-old female who presented with intermittent high fever and intractable neck, shoulder, and back pain for two months. She was diagnosed with <i>Brucella</i> cervical spondylitis based on clinical manifestations, Rose-Bengal Plate Agglutination Test (RBPT, positive), and cervical MRI findings. She was treated with a combination of antibiotics for at least two weeks, followed by surgical intervention including abscess clearance, partial vertebral resection, and titanium mesh bone fusion. Real-time Polymerase Chain Reaction (RT-PCR) confirmed the presence of sheep <i>Brucella</i> DNA. The patient recovered well postoperatively with significant pain reduction and restoration of full mobility in the right upper limb.</p><p><strong>Conclusion: </strong>This case highlights the diagnostic value of RT-PCR and tissue biopsy in cervical brucellosis spondylitis. Our study found that anterior cervical subtotal corpectomy can restore cervical stability, clear abscess, and relieve spinal cord compression on the basis of drug treatment, with good clinical results.</p>","PeriodicalId":13577,"journal":{"name":"Infection and Drug Resistance","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11330751/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142004123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}